Discretionary screen time, reported by parents or self, was assessed in relation to a composite cardiometabolic risk score ...

Welcome, listeners, now to August 19th and this issue of Circulation on the Run. And I'm one of your co-hosts, Dr. Greg Hundley, Director of the Pauley Heart Center at VCU Health in Richmond, Virginia ...

BACKGROUND: Endogenous retroviruses (ERVs) occupy >8% of the human genome. Aberrant resurgence of ERVs has been implicated recently in several critical pathologies. However, the possible incidence and ...

Keyhani S, Cohen BE, Vali M, Hoggatt KJ, Bravata DM, Austin PC, Lum E, Hasin D, Grunfeld C, Shlipak MG. Association of smoking cannabis with cardiovascular events among veterans with coronary artery ...

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are ...

A55-year-old man with a history of paroxysmal atrial fibrillation, hypertension, and stroke presented to the emergency room with the acute onset of shortness of breath. He had previously been ...

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are ...

Get full access to this article View all available purchase options and get full access to this article.

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are ...

For decades, government investment in biomedical research has driven breakthrough advances in science, medicine, and public health, particularly in cardiovascular care and brain health. These ...

Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human Atherosclerosis ...

Letter by Pasupathy et al Regarding Article, “Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial” ...